Who owns TAKEDA PHARMACEUTICAL CO LTD?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TAK from SEC Form 13F filings across 396 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 396 institutions disclosed 122.6M shares of TAKEDA PHARMACEUTICAL CO LTD worth $2.23B — about 3.9% of shares outstanding; the largest disclosed holder is Capital Research Global Investors. Source: SEC Form 13F filings, parsed by EvidInvest.
396
13F holders
$2.23B
value, 2026 filers
3.9%
of shares outstanding (122.6M sh)
66
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TAK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Capital Research Global Investors | 27.0M | $490.3M | 0.1% | 0.9% | +39.7% |
| 2 | FMR LLC | 11.0M | $199.6M | 0.0% | 0.3% | +14.3% |
| 3 | MORGAN STANLEY | 8.2M | $149.8M | 0.0% | 0.3% | +17.7% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.2M | $131.0M | 0.2% | 0.2% | +19.0% |
| 5 | GOLDMAN SACHS GROUP INC | 5.5M | $100.8M | 0.0% | 0.2% | +8.1% |
| 6 | BRANDES INVESTMENT PARTNERS, LP | 4.2M | $77.1M | 0.5% | 0.1% | -6.6% |
| 7 | BlackRock, Inc. | 3.9M | $71.6M | 0.0% | 0.1% | +6.8% |
| 8 | D. E. Shaw & Co., Inc. | 3.1M | $57.1M | 0.0% | 0.1% | +53.2% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.0M | $54.5M | 0.0% | 0.1% | -19.8% |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 2.3M | $41.7M | 0.1% | 0.1% | -10.7% |
| 11 | Qube Research & Technologies Ltd | 2.2M | $39.2M | 0.0% | 0.1% | -2.4% |
| 12 | JPMORGAN CHASE & CO | 2.0M | $36.3M | 0.0% | 0.1% | +163.2% |
| 13 | MANAGED ASSET PORTFOLIOS, LLC | 1.8M | $33.0M | 3.7% | 0.1% | -0.6% |
| 14 | FIRST TRUST ADVISORS LP | 1.8M | $32.8M | 0.0% | 0.1% | -14.7% |
| 15 | NORTHERN TRUST CORP | 1.6M | $29.9M | 0.0% | 0.1% | -5.7% |
| 16 | Quantinno Capital Management LP | 1.6M | $29.3M | 0.0% | 0.1% | +15.0% |
| 17 | TWO SIGMA INVESTMENTS, LP | 1.6M | $29.0M | 0.0% | 0.1% | +228.4% |
| 18 | AQR CAPITAL MANAGEMENT LLC | 1.5M | $28.2M | 0.0% | 0% | +1.4% |
| 19 | VAN ECK ASSOCIATES CORP | 1.5M | $28.0M | 0.0% | 0% | -8.1% |
| 20 | XY Capital LtdNEW | 1.4M | $25.6M | 22.1% | 0% | new |
| 21 | MILLENNIUM MANAGEMENT LLC | 1.3M | $24.2M | 0.0% | 0% | +26.9% |
| 22 | ENVESTNET ASSET MANAGEMENT INC | 1.3M | $23.6M | 0.0% | 0% | -18.8% |
| 23 | BNP PARIBAS FINANCIAL MARKETS | 1.1M | $19.6M | 0.0% | 0% | +50.8% |
| 24 | WELLS FARGO & COMPANY/MN | 1.1M | $19.5M | 0.0% | 0% | -6.6% |
| 25 | CITADEL ADVISORS LLC | 798,062 | $14.5M | 0.0% | 0% | +374.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.